CC
TGTX icon

Cipher Capital’s TG Therapeutics TGTX Stock Holding History

Cipher Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$175K Buy
+11,525
New +$184K 0.08% 379
2022
Q4 		– Sell
-10,499
Closed -$62K – 643
2022
Q3 		$62K Buy
+10,499
New +$68.9K 0.01% 411

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cipher Capital's TGTX Position: Q1 2024 in Review

Cipher Capital opened a new position in TG Therapeutics (TGTX) in Q1 2024: 11,525 shares worth $175K. The stake represents 0.08% of the portfolio and ranks #379 among its holdings. This is a return to the name: Cipher Capital previously reported a position in TGTX as recently as Q3 2022.

Cipher Capital first reported a position in TGTX in Q3 2022 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

  • Cipher Capital held 11,525 shares of TG Therapeutics worth $175K as of Q1 2024.
  • TG Therapeutics was a new Cipher Capital position in Q1 2024.
  • TG Therapeutics made up 0.08% of Cipher Capital's portfolio in Q1 2024, its #379 holding.
  • Cipher Capital first reported a position in TG Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.